|
HS Code |
835813 |
| Product Name | Prednisone Acetate Tablets Veterinary Grade API |
| Appearance | White or almost white crystalline powder |
| Molecular Formula | C23H30O6 |
| Molecular Weight | 402.48 g/mol |
| Purity | ≥99% |
| Solubility | Practically insoluble in water; soluble in alcohol, chloroform and acetone |
| Stability | Stable under normal temperatures and pressures |
| Storage Conditions | Store in a cool, dry place away from light |
| Intended Use | API for Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Pharmacological Class | Glucocorticoid corticosteroid |
| Cas Number | 125-10-0 |
| Shelf Life | 36 months |
As an accredited Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, sealed HDPE bottle containing 500 grams of Prednisone Acetate Tablets Veterinary Grade API, labeled for pharmaceutical manufacturing use only. |
| Shipping | Prednisone Acetate Tablets (Veterinary Grade API) are securely packed in moisture-proof, tamper-evident containers. Shipments comply with international safety standards, using temperature-controlled transport as required. Documentation includes COA and MSDS. Suitable for delivery in bulk or customized quantities for tablets, injections, capsules, powders, granules, premix, and solutions. |
| Storage | Store Prednisone Acetate Tablets (Veterinary Grade API) in a tightly sealed container at 15–30°C (59–86°F), protected from light, moisture, and direct heat. Keep in a dry, well-ventilated area, away from incompatible substances. Ensure storage is secure and restricted to authorized personnel. Avoid freezing and keep out of reach of children, pets, or unauthorized individuals. |
|
Purity 99%: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a purity of 99% is used in veterinary anti-inflammatory therapy, where it ensures consistent pharmacological efficacy and minimized impurities in formulations. Micronized Particle Size D90 <10 µm: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions featuring a micronized particle size D90 <10 µm is used in oral tablet production, where it enables rapid dissolution and enhanced bioavailability in companion animals. Stability Temperature ≤ 40°C: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions stable at temperatures ≤ 40°C is used in injectable veterinary solutions, where it maintains chemical integrity during storage and transportation. Low Moisture Content ≤ 1.0%: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with moisture content ≤ 1.0% is used in granule and premix formulations, where it prevents agglomeration and ensures free-flowing powder consistency. Molecular Weight 402.5 g/mol: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a molecular weight of 402.5 g/mol is used in veterinary capsule preparations, where it guarantees precise dosage calculation and reliable pharmacokinetics. High Solubility in Ethanol: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with high solubility in ethanol is used for compounded veterinary solutions, where it enables uniform active ingredient distribution in liquid dosage forms. Melting Point 230–235°C: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a melting point range of 230–235°C is used in the manufacturing of stable tablet cores, where it supports processability under standard thermal conditions. USP/EP Compliance: Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions meeting USP/EP compliance is used in multi-dosage veterinary medicinal products, where it verifies regulatory-approved quality and promotes safety in animal health applications. |
Competitive Prednisone Acetate Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Building reliable pharmaceuticals for animals takes more than access to raw materials. It calls for experience, careful process control, and long-term consistency. In the decades we've spent manufacturing Prednisone Acetate Tablets in our facilities, we've witnessed up close how this active ingredient has carved out its place as a cornerstone in veterinary practice. Not every corticosteroid comes with the versatility, stability, and ease of formulation that Prednisone acetate delivers. Animal health demands solutions that withstand transportation, mixing, and storage — and not every product holds up. Through repeated feedback from veterinary formulators and contract manufacturing partners, and through our own batch analytics, we see where the challenges tend to show up. Tablets crumble, powders settle unevenly, and granules clump during mixing under less-than-ideal manufacturing. Our process focuses on getting past these common headaches.
Each step in our batch production, sampling, and tableting process builds on years of chemical engineering know-how. We maintain strict control of particle size distribution, moisture parameters, and binders to guarantee shelf-stable performance for both tablet and powder forms. Granules roll out with a dense, dust-controlled profile, making them easier for downstream blending — this isn’t an accident. We’ve invested in real-time in-process checks for hardness, friability, and mass uniformity, since only solid data confirms reproducible quality and easy downstream processing.
Quality doesn’t begin at the final blend or filtration step. From our own upstream supply, we inspect the acetylation stage, double-checking for over-acetylated or under-reacted intermediates that can cause brittle tablets, slow dissolution, or unwanted breakdown during storage. We test finished API in both acidic and basic dissolution media to catch any signs of ''slow-release'' behaviors that can sneak into blends, whether destined for tablets, capsules, or injectable suspensions. Laboratory evaluation under stress shows the stability profile holds up in environmental chambers simulating real-world shipment conditions — not just an air-conditioned lab.
We run multiple strengths and batch sizes depending on veterinary demand. Most common are 5 mg and 20 mg tablet models, pressed with robust binders for consistent weight and break strength. No one likes tablets that splinter in the bottle; we've engineered against this with careful binder choice and compaction force testing.
Some veterinary applications call for larger format, high-dose tablets — for instance, into routine large animal anti-inflammatory protocols — while small-animal veterinarians request precise, low-dose forms for sensitive dosing. Over the years, we've tuned our mixing and granulation parameters to flex for these different models. Our experience has taught us that granules for premix need a different profile than those heading into direct-compression tablets. Floating dust and poor flow slow mixing, cause losses, and don't belong in dependable product runs. By measuring and adjusting median particle size and keeping a tight eye on agglomeration, we cut down on wasted blend and save time for formulators in the field.
Tablets aren't always the answer. In some farm or field treatment settings, water-soluble forms or powders for feed mixing offer faster, broader delivery. We manufacture Prednisone acetate as a directly dispersible powder for both drinking water solutions and feed premix. Real-world mixing needs more than just labeled assay; it requires anti-caking performance and low residue after blending. Our dry blending and spray-drying processes build this characteristic into the finished material.
For capsule production, particularly in cases where precise dose titration is vital (as in avian or exotics), particle flow rates and easy fill matter. We support these lines with an API variant having tuned flowability, confirmed through angle-of-repose and bulk density testing. If a veterinary client needs a fine, taste-masked powder for oral syringes or paste, we've worked flavorless variants into the process — not masked by excipients, but by strict recrystallization control and impurity management.
Injectable suspensions present a different challenge. Prednisone acetate must remain stable and evenly suspended in non-aqueous vehicles without rapid settlement or clumping. Tackling this calls for ultra-fine API, made possible by thorough micronization and rigorous post-process sieving. Every batch destined for injection undergoes aseptic-grade packaging and microbial challenge testing; tablet and granule lines aren’t exposed to this level of scrutiny, due to the higher sensitivity of parenteral applications. Again, this is knowledge learned not overnight but through years of close feedback with pharmaceutical partners and in-market product reviews.
Prednisone acetate plays an enormous role in therapeutic protocols for animals, especially where immune modulation, anti-inflammatory, or adrenal support treatment is called for. Equine specialists often come to us for bulk API to manage joint and soft tissue conditions; small animal practitioners look for reliable tablet strengths when adjusting for creature-to-creature variation in pets. Animal nutritionists designing premix blends for poultry and swine need dust-free, pourable powders to add into feed lines — resistant to clumping and easy to measure, so no dose goes missing.
Over time, veterinarians have shared with us why off-the-shelf products sometimes disappoint. Tablets pressed from generic API can chip or crumble when subjected to high humidity or shipping vibration — capsules won’t fill right when powder doesn’t flow — and suspensions settle out into sticky, hard-to-redisperse layers. Tackling each of these issues pushed us to overhaul our purification, drying, and tableting strategy. The result: veterinary-grade API that not only passes compendial standards but stays workable and stable in daily clinical use. We’ve listened as veterinarians describe practice-side needs, then set out to supply material that functions day-in, day-out, even in the less than ideal storage conditions of a remote feedroom or clinic.
Not all corticosteroids share the same chemical structure or formulation challenges. Prednisone acetate’s solubility, ease of micronization, and stable crystallinity separate it from other actives like dexamethasone or prednisolone sodium phosphate. Excess water uptake can ruin some API in storage or cause caking in powders — our manufacturing process controls incoming humidity and post-drying residual moisture. Tablets or powders that pick up grit or compact unevenly during distribution always trace back to loose controls at the drying or granulation stage. By refining oven dwell times, filtration cycles, and air handling, we maintain particle consistency down to a tight margin batch-to-batch.
Veterinarians see the impact in simpler dosing, easier tablet splitting, and longer storage periods without potency dips or visible spoilage. Many of our clients have noted the marked difference in appearance, feel, and mixing ease with our products compared to lower-grade imports. This comes from persistent process tuning, not by accident, but as a commitment to better animal care. The animal world doesn't run on theoretics and white papers; it runs on practical, repeatable experience. Only material made to suit real-life conditions can keep pace.
Cutting corners in this industry usually doesn’t show up in brochures; it manifests through field complaints. Chalky tablets, separation in blends, off-color powders, or assay losses after storage. We’ve seen how seemingly minor changes in excipients, binder ratios, or particle controls cascade into front-line headaches. For this reason, every finished batch carries not just analytical approval, but ongoing stability assessments and full processing traceability.
Commercial manufacturing rarely runs in a perfect environment. Seasonal shifts in humidity or temperature sneak in, and raw material quality can fluctuate based on global supply chain hiccups. We've outfitted our lines with closed-loop climate control around mixing, granulation, and pressing. Regular recalibration of equipment, random tablet checks every run, and cross-validation between chemical and physical testing add layers of assurance. Instead of banking on a single ''release test'', we rely on process-driven, in-line standards to weed out weak spots before they make it out the door.
Our supply doesn’t just stop with bulk API. We work with animal health formulators to troubleshoot tricky projects, from large-scale farm feed premixes to niche exotic animal capsules. Some clients ask us to adapt the tablet’s size, shape, or hardness for species with special administration needs — for example, adjusting disintegration rates for slow-release or flavor-masking for sensitive species. It’s not unusual for a practitioner to call and describe trouble splitting a generic tablet for a finicky feline patient, or to report difficulty dispersing a powder into drinking water. Having that line open allows us to adjust future production, refine tablet or powder formulations, and improve binder or coating selections.
Take, for instance, bulk granules destined for feed plant mixing. These clients require product that won’t segregate or create ''hot spots'' in blend tanks. By testing granule friability, angle of repose, and dust content, we cut down on lost API and inconsistent dosing in finished feed. Where injection-grade API is needed, we laser in on particle size and surface area, since these parameters drive the rate of suspension and clarity in injectable solutions.
Field veterinarians and farm producers, who must work with what’s at hand, prefer materials that do not demand overly specialized equipment or narrow storage parameters. We track these practical needs and build material properties—such as non-caking nature, minimized static, and higher pellet integrity—into every run. A feedmill can adjust its dosing hoppers or screw conveyors only so much; the product that works again and again fits existing equipment, not the other way around. We keep direct lines to technical support open for feedback on how our material is performing in live environments — not just in our test lab or in theoretical blend simulations.
Every practitioner, whether working in large animal medicine or small companion animal clinics, faces recurring frustration with batch variation. Animals aren’t uniform machines, and neither are their dosing regimens. From our vantage on the manufacturing floor, it's clear that maintaining a stable product profile remains the linchpin of success. Granules pressed too hard turn into rocks in premix; too loose, and flow suffers. We tune compaction force profiles for each batch through constant monitoring.
Tablet hardness, moisture resistance, and scoreline centering matter. Veterinarians often break tablets to tailor dosing; if a tablet crumbles apart or holds an unpredictable dose, the impact shows up in the animal, not just a record. Every run, we sample and test splitability and breaking force, not just in controlled lab settings but in the context of practical clinical use. Powders and granules are likewise checked for segregation and recovery after multiple transfers, since repeated handling is a fact of life outside the factory.
Responsible veterinary pharmaceutical production goes beyond meeting local or international standards. The industry has seen its share of supply scandals, so we focus on rigorous lot tracking and full transparency during the blending, drying, and finishing stages. Batch records from our facilities travel with every shipment, allowing any downstream issue to be traced straight back to the root cause — whether in excipient variability, environmental monitoring, or operator deviation. We have lived through long, stressful investigations caused by single-batch slips in global supply chains, and know the value of keeping documentation bulletproof from the start.
In our experience, practitioners and pharmacy customers are more interested in transparent answers than in marketing gloss. We encourage veterinary pharmacists to raise any flag — a change in taste, color, dispersibility, or handling — since only open feedback drives improvement. Product recalls and field failures don’t keep anyone supplied; a reliable process and honest communication do.
Veterinary science adapts. Indications shift, administration methods grow more precise, and clients call for cleaner, safer, more effective pharmaceuticals. We invest not only in meeting current compendial standards but in raising our own barrier for impurity control and shelf-life performance. Whether that means refining our drying and filtration cycles, advancing new coating technologies for more robust tablets, or zeroing in on microbial barriers for targeted parenteral use, our production line pivots to where real need appears.
Environmental factors can never be ignored. We’ve equipped our waste processing and solvent recovery systems to minimize off-gas, reduce chemical footprints, and drive up yield. As regulatory landscapes move toward tighter oversight and higher active purity, our response has always been to get ahead of deadlines — adopt new in-process checks, integrate green chemistry steps, and design new formulations that match what veterinarians will ask for, not just what they settle for today.
Having a clear sightline into the manufacturing process distinguishes API suppliers from intermediaries and repackagers. We solve formulation snags, provide stability data, and troubleshoot mixing or tableting issues because we make the material ourselves. Our laboratory and manufacturing teams cycle with practitioner feedback, not just regulatory audits, to target improvement. Success for us means fewer surprises on the clinic or farm floor — more consistent medications, less product loss, and better animal outcomes.
Prednisone acetate tablets, powders, granules, premixes, capsules, and injectable forms roll out from our facilities with real-world durability. Whether the need is a split-tablet for a housecat, bulk powder for poultry, or a stabilized suspension for sterile injection, our process aims at providing a practical, workable answer for any veterinary challenge — not just meeting the status quo but pushing it forward. Our experience proves that manufacturing isn’t about filling quotas; it’s about understanding the veterinarian’s day-to-day work and supplying them with products ready for anything the animal health world brings.